Rola Piotr, Włodarczak Adrian, Kulczycki Jan J, Barycki Matuesz, Furtan Łukasz, Pęcherzewski Maciej, Szudrowicz Marek, Włodarczak Szymon, Doroszko Adrian, Lesiak Maciej
Department of Cardiology, Provincial Specialized Hospital Legnica, Legnica, Poland.
Department of Cardiology, The Copper Health Centre (MCZ), Lubin, Poland.
Postepy Kardiol Interwencyjnej. 2021 Dec;17(4):344-348. doi: 10.5114/aic.2021.112524. Epub 2021 Dec 30.
Left main (LM) disease is associated with a large myocardial ischemic territory. Calcification with co-existing undilatable lesions is a predictor of poor clinical outcomes following LM percutaneous coronary interventions (PCI).
To evaluate the safety and efficiency of shockwave intravascular lithotripsy (S-IVL) in highly calcified LM diseases.
The study population consisted of sixteen patients qualified for PCI - mainly males (81.3%) with coronary artery disease (CAD) treated with left main S-IVL PCI due to unsuccessful attempts of plaque modification with a non-compliant (NC) balloon catheter, or rotational devices. Clinical success was defined as effective stent delivery and deployment (with less than < 20% in-stent residual stenosis) with preserved coronary flow TIMI-3 (Thrombolysis in Myocardial Infarction) at the end of the procedure.
The most frequent indication for PCI was acute coronary syndrome (ACS) (62.5%). In these high-risk (average Syntax score 24) patients, clinical success of PCI was achieved in 100% of cases. In the short-term observation, we recorded two major adverse cardiac and cerebrovascular events (MACCE) including one fatal, acute stent thrombosis.
Our data suggest that the use of S-IVL is safe and effective as a bail-out strategy to manage LM lesions resistant to high-pressure NC balloon inflation. Despite encouraging initial results, future large studies with long-term observation are required to evaluate the safety and efficacy of S-IVL in LM stenosis.
左主干(LM)病变与大面积心肌缺血区域相关。钙化合并不可扩张病变是LM经皮冠状动脉介入治疗(PCI)后临床预后不良的预测指标。
评估冲击波血管内碎石术(S-IVL)治疗高度钙化LM病变的安全性和有效性。
研究人群包括16例符合PCI条件的患者,主要为男性(81.3%),患有冠状动脉疾病(CAD),因使用非顺应性(NC)球囊导管或旋磨装置进行斑块修饰未成功而接受左主干S-IVL PCI治疗。临床成功定义为在手术结束时有效输送和植入支架(支架内残余狭窄小于20%),并保持冠状动脉血流TIMI-3级(心肌梗死溶栓分级)。
PCI最常见的适应证是急性冠状动脉综合征(ACS)(62.5%)。在这些高危(平均Syntax评分24)患者中,100%的病例实现了PCI临床成功。在短期观察中,我们记录了2例主要不良心脑血管事件(MACCE),包括1例致命的急性支架血栓形成。
我们的数据表明,作为一种补救策略,使用S-IVL治疗对高压NC球囊扩张有抵抗的LM病变是安全有效的。尽管初步结果令人鼓舞,但需要未来进行长期观察的大型研究来评估S-IVL治疗LM狭窄的安全性和有效性。